HANSON; DOUGLAS C.
Patent Applications and Registrations
Patent applications and USPTO patent grants for HANSON; DOUGLAS C..The latest application filed is for "combination motif immune stimulatory oligonucleotides with improved activity".
- HANSON; DOUGLAS C. - NIANTIC CT
- Hanson; Douglas C - Niantic CT
| Patent | Date |
|---|---|
| Combination Motif Immune Stimulatory Oligonucleotides With Improved Activity App 20120219571 - VOLLMER; JORG ; et al. | 2012-08-30 |
| Combination motif immune stimulatory oligonucleotides with improved activity Grant 8,198,251 - Vollmer , et al. June 12, 2 | 2012-06-12 |
| Combination Motif Immune Stimulatory Oligonucleotides With Improved Activity App 20090087446 - VOLLMER; JORG ; et al. | 2009-04-02 |
| Nucleic acids encoding human monoclonal antibodies to CTLA-4 Grant 7,411,057 - Hanson , et al. August 12, 2 | 2008-08-12 |
| Uses of anti-CTLA-4 antibodies App 20050226875 - Gomez-Navarro, Jesus ; et al. | 2005-10-13 |
| Uses of anti-CTLA-4 antibodies App 20030086930 - Mueller, Eileen E. ; et al. | 2003-05-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 